Literature DB >> 16775917

Successful use of combination antifungal therapy in the treatment of coccidioides meningitis.

Suresh J Antony1, Peter Jurczyk, Lisa Brumble.   

Abstract

Coccidioidal meningitis is a highly lethal condition with a high morbidity and relapse rate caused by Coccidioides immitis. This case report highlights the difficulty in diagnosing and treating coccidioidal meningitis, and discusses a novel combination antifungal therapy (voriconazole and liposomal amphotericin B), which was used to treat this patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775917      PMCID: PMC2569371     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  17 in total

Review 1.  Clinical pharmacology of antifungal compounds.

Authors:  Andreas H Groll; Juan C Gea-Banacloche; Axel Glasmacher; Gudrun Just-Nuebling; Georg Maschmeyer; Thomas J Walsh
Journal:  Infect Dis Clin North Am       Date:  2003-03       Impact factor: 5.982

2.  Successful use of voriconazole for treatment of Coccidioides meningitis.

Authors:  Laurie A Proia; Allan R Tenorio
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

3.  Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.

Authors:  K N Sorensen; R A Sobel; K V Clemons; D Pappagianis; D A Stevens; P L Williams
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

4.  In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.

Authors:  R K Li; M A Ciblak; N Nordoff; L Pasarell; D W Warnock; M R McGinnis
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 5.  Voriconazole: a new triazole antifungal agent.

Authors:  Leonard B Johnson; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2003-02-10       Impact factor: 9.079

6.  Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.

Authors:  Karl V Clemons; Raymond A Sobel; Paul L Williams; Demosthenes Pappagianis; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

7.  A murine model of coccidioidal meningitis.

Authors:  Perparim Kamberi; Raymond A Sobel; Karl V Clemons; David A Stevens; Demosthenes Pappagianis; Paul L Williams
Journal:  J Infect Dis       Date:  2003-01-24       Impact factor: 5.226

8.  Coccidioidomycosis.

Authors:  Tom M Chiller; John N Galgiani; David A Stevens
Journal:  Infect Dis Clin North Am       Date:  2003-03       Impact factor: 5.982

9.  Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis.

Authors:  Suresh Antony; Delfina C Dominguez; Elsa Sotelo
Journal:  J Natl Med Assoc       Date:  2003-10       Impact factor: 1.798

10.  Successful treatment of coccidioidal meningitis with voriconazole.

Authors:  Karoll J Cortez; Thomas J Walsh; John E Bennett
Journal:  Clin Infect Dis       Date:  2003-06-09       Impact factor: 9.079

View more
  6 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

2.  The role of second-generation antifungal triazoles for treatment of the endemic mycoses.

Authors:  Alison G Freifeld; J Ryan Bariola; David Andes
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

3.  Voriconazole use for endemic fungal infections.

Authors:  Alison Freifeld; Laurie Proia; David Andes; Larry M Baddour; Janis Blair; Brad Spellberg; Sandra Arnold; Arnold Lentnek; L Joseph Wheat
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

4.  Pharmacokinetics of nikkomycin Z after single rising oral doses.

Authors:  David E Nix; Robert R Swezey; Richard Hector; John N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

5.  Coccidioidal meningitis: update on epidemiology, clinical features, diagnosis, and management.

Authors:  Janis E Blair
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

Review 6.  Central Nervous System Infections Due to Coccidioidomycosis.

Authors:  Niki R Jackson; Janis E Blair; Neil M Ampel
Journal:  J Fungi (Basel)       Date:  2019-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.